The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Nanotechnology in ocular drug delivery
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Microemulsion-based media as novel drug delivery systems
Lawrence, M. J., & Rees, G. D. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00103-4 · Cited by 2,040
Nanotech approaches to drug delivery and imaging
Sahoo, S. K., & Labhasetwar, V. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02903-9 · Cited by 1,203
Self-citationCyclodextrins in drug delivery
Loftsson, T., Jarho, P., Másson, M., & Järvinen, T. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.1.335 · Cited by 793
Ophthalmic drug delivery systems—Recent advances
Le Bourlais, C., Acar, L., Zia, H., Sado, P. A., Needham, T., & Leverge, R. (1998) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(97)00002-5 · Cited by 698
De Campos, A. M., Sánchez, A., & Alonso, M. J. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00760-8 · Cited by 666
Quintana, A., Raczka, E., Piehler, L., Lee, I., Myc, A., Majoros, I., Patri, A. K., Thomas, T., Mulé, J., & Baker, J. R. (2002) · Pharmaceutical Research · doi:10.1023/a:1020398624602 · Cited by 663
A PEGylated dendritic nanoparticulate carrier of fluorouracil
Bhadra, D., Bhadra, S., Jain, S., & Jain, N. K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00132-7 · Cited by 544
Polyester Dendritic Systems for Drug Delivery Applications: In Vitro and In Vivo Evaluation
Padilla De Jesús, O. L., Ihre, H. R., Gagne, L., Fréchet, J. M. J., & Szoka, F. C. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010103m · Cited by 507
Vesicular systems in ocular drug delivery: an overview
Kaur, I. P., Garg, A., Singla, A. K., & Aggarwal, D. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.016 · Cited by 450
Vandamme, T. F., & Brobeck, L. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.015 · Cited by 401
Engineered nanoparticles as precise drug delivery systems
Yih, T. C., & Al‐Fandi, M. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20796 · Cited by 392
Felt, O. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00003-4 · Cited by 358
Bourges, J.-L., Gautier, S. E., Delie, F., Bejjani, R. A., Jeanny, J.-C., Gurny, R., BenEzra, D., & Behar-Cohen, F. F. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1068 · Cited by 357
Guinedi, A. S., Mortada, N. D., Mansour, S., & Hathout, R. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.09.023 · Cited by 355
The Impact of Nanobiotechnology on the Development of New Drug Delivery Systems
Kayser, O., Lemke, A., & Hernandez-Trejo, N. (2005) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201053167158 · Cited by 349
Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers
Calvo, P., Vila-Jato, J. L., & Alonso, M. J. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00083-5 · Cited by 347
Microemulsions as ocular drug delivery systems: recent developments and future challenges
Vandamme, T. F. (2002) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00017-9 · Cited by 345
Polyester Dendritic Systems for Drug Delivery Applications: Design, Synthesis, and Characterization
Ihre, H. R., Padilla De Jesús, O. L., Szoka, & Fréchet, J. M. J. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010102u · Cited by 332
Targeted Drug Delivery in Cancer Therapy
Vasir, J. K., & Labhasetwar, V. (2005) · Technology in Cancer Research & Treatment · doi:10.1177/153303460500400405 · Cited by 327
Cyclodextrins in ophthalmic drug delivery
Loftssona, T. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00055-6 · Cited by 305
Ophthalmic Drug Delivery through Contact Lenses
Gulsen, D., & Chauhan, A. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0959 · Cited by 304
Treatment of Cytomegalovirus Retinitis with a Sustained-Release Ganciclovir Implant
Musch, D. C., Martin, D. F., Gordon, J. F., Davis, M. D., & Kuppermann, B. D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370203 · Cited by 286
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application
Pignatello, R., Bucolo, C., Spedalieri, G., Maltese, A., & Puglisi, G. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00080-7 · Cited by 285
Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle
Gulsen, D., & Chauhan, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.11.033 · Cited by 277
Drug delivery to the retina: challenges and opportunities
Duvvuri, S., Majumdar, S., & Mitra, A. K. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.1.45 · Cited by 249
De Campos, A. M., Sánchez, A., Gref, R., Calvo, P., & Alonso, M. J. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00178-7 · Cited by 234
Drug delivery systems for vitreoretinal diseases
Yasukawa, T., Ogura, Y., Tabata, Y., Kimura, H., Wiedemann, P., & Honda, Y. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.02.003 · Cited by 232
Sanborn, G. E. (1992) · Archives of Ophthalmology · doi:10.1001/archopht.1992.01080140044023 · Cited by 230
Hicks, D., & Molday, R. S. (1986) · Experimental Eye Research · doi:10.1016/0014-4835(86)90017-5 · Cited by 228
Polyamidoamine Starburst® dendrimers as solubility enhancers
Milhem, O. M., Myles, C., McKeown, N. B., Attwood, D., & D’Emanuele, A. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00463-9 · Cited by 227
Pathology of experimental autoimmune uveoretinitis in mice
Chan, C.-C., Caspi, R. R., Ni, M., Leake, W. C., Wiggert, B., Chader, G. J., & Nussenblatt, R. B. (1990) · Journal of Autoimmunity · doi:10.1016/0896-8411(90)90144-h · Cited by 202
New vehicle based on a microemulsion for topical ocular administration of dexamethasone
Fialho, S. L., & Da Silva‐Cunha, A. (2004) · Clinical & Experimental Ophthalmology · doi:10.1111/j.1442-9071.2004.00914.x · Cited by 193
Ooya, T. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.07.001 · Cited by 179
Kawashima, Y., Niwa, T., Handa, T., 洋文, 竹., Iwamoto, T., & Itoh, K. (1989) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600780118 · Cited by 178
Nanotechnology-based Drug Delivery for Cancer
Jain, K. K. (2005) · Technology in Cancer Research & Treatment · doi:10.1177/153303460500400408 · Cited by 161
Effect of Particle Size of Polymeric Nanospheres on Intravitreal Kinetics
Sakurai, E., Ozeki, H., Kunou, N., & Ogura, Y. (2000) · Ophthalmic Research · doi:10.1159/000055638 · Cited by 156
Design of Controlled Release Drug Delivery Systems
Li, X., & Jasti, B. (2005) · Cited by 154
Review of Ocular Drug Delivery
Sultana, Y., Jain, S., Aqil, M., & Ali, A. (2006) · Current Drug Delivery · doi:10.2174/156720106776359186 · Cited by 143
Labhasetwar, V. D. (2005) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2005.10.009 · Cited by 138
Merodio, M., Irache, J. M., Valamanesh, F., & Mirshahi, M. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00284-8 · Cited by 132
Albumin Nanoparticles for the Intravitreal Delivery of Anticytomegaloviral Drugs
Irache, J. M., Merodio, M., Arnedo, A., Camapanero, M., Mirshahi, M., & Espuelas, S. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557053175335 · Cited by 131
Bochot, A., Fattal, E., Gulik, A., et al. (1998) · Pharmaceutical Research · doi:10.1023/a:1011989202488 · Cited by 121
Development of a topical niosomal preparation of acetazolamide: preparation and evaluation
Aggarwal, D., Garg, A. B., & Kaur, I. P. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357044896 · Cited by 121
Disposition of timolol and inulin in the rabbit eye following corneal versus non-corneal absorption
Ahmed, I. I. K., & Patton, T. F. (1987) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(87)90092-5 · Cited by 119
Ocular Drug Delivery: Nanomedicine Applications
Vandervoort, J., & Ludwig, A. (2007) · Nanomedicine · doi:10.2217/17435889.2.1.11 · Cited by 114
Effect of Cyclodextrins on Topical Drug Delivery to the Eye
Loftsson, Þ., & Stefánsson, E. (1997) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049709148496 · Cited by 113
Preparation and evaluation of acetazolamide liposomes as an ocular delivery system
El-Gazayerly, O. N., & Hikal, A. H. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00186-5 · Cited by 113
Intravitreal delivery of oligonucleotides by sterically stabilized liposomes.
Bochot, A., Fattal, E., Boutet, V., Deverre, J. R., Jeanny, J., Chacun, H., & Couvreur, P. (2002) · PubMed · Cited by 98
Koevary, S. B. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489488 · Cited by 98
Chader, G. J. (1989) · PubMed · Cited by 94
Kristinsson, J. K., Friðriksdóttir, H., Thórisdóttir, S., et al. (1996) · PubMed · Cited by 94
Ocular drug delivery of progesterone using nanoparticles
Li, V. H. K., Wood, R. W., Kreuter, J., Harmia, T., & Robinson, J. R. (1986) · Journal of Microencapsulation · doi:10.3109/02652048609031575 · Cited by 83
Usayapant, A., Karara, A. H., & Narurkar, M. M. (1991) · Pharmaceutical Research · doi:10.1023/a:1015838215268 · Cited by 77
Discoidal niosome based controlled ocular delivery of timolol maleate.
Vyas, S. P., Mysore, N., Jaitely, V., & Venkatesan, N. (1998) · PubMed · Cited by 76
Naveh, N., Muchtar, S., & Benita, S. (1994) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1994.10.509 · Cited by 68
Transporters and receptors in ocular drug delivery: opportunities and challenges
Dey, S., & Mitra, A. K. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.2.201 · Cited by 56
Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit
Wong, C. G., Rich, K. A., Liaw, L. L., Hsu, H. T., & Berns, M. W. (2001) · Current Eye Research · doi:10.1076/ceyr.22.2.140.5528 · Cited by 55
Caspi, R. R., Chan, C., Leake, W. C., Higuchi, M., Wiggert, B. O., & Chader, G. J. (1990) · Journal of Autoimmunity · doi:10.1016/0896-8411(90)90143-g · Cited by 54
Influence of Hydroxypropyl β-Cyclodextrin on the Corneal Permeation of Pilocarpine
Aktaş, Y., Ünlü, N., Orhan, M., Irkec, M. T., & Hıncal, A. A. (2003) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120016730 · Cited by 38
Béhar‐Cohen, F. (2004) · médecine/sciences · doi:10.1051/medsci/2004206-7701 · Cited by 15
Cited by
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Acharya, S., & Sahoo, S. K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.10.008 · Cited by 1,112
Self-citationRecent Perspectives in Ocular Drug Delivery
Gaudana, R., Jwala, J., Boddu, S. H. S., & Mitra, A. K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 605
Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy
Parhi, P., Mohanty, C., & Sahoo, S. K. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.05.010 · Cited by 573
Self-citationMandal, A., Bisht, R., Rupenthal, I. D., & Mitra, A. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.012 · Cited by 481
Nanoparticles: Taking a Unique Position in Medicine
Joseph, T., Kar Mahapatra, D., Esmaeili, A., Piszczyk, Ł., Hasanin, M., Kattali, M., Haponiuk, J., & Thomas, S. (2023) · Nanomaterials · doi:10.3390/nano13030574 · Cited by 480
Metadata
- Authors
- Sahoo, S. K., Dilnawaz, F., & Krishnakumar, S.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 13
- Issue
- 3-4
- Pages
- 144-151
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2125010860
- Cited by
- 510
- References
- 61
- FWCI
- 11.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.